NewsSource: EClinCloud

Product Overview | CTMS: Clinical Trial Management System

2 min readEClinCloud Editorial Team
Article figure

Source: EClinCloud. Author: EClinCloud.

Article figure


As regulatory requirements grow increasingly stringent, quality standards for clinical trials continue to rise, and domestic standardization and normalization increasingly align with international levels, managing projects more efficiently and ensuring clinical research compliance have become especially important.


What is EClinCloud CTMS?

The EClinCloud CTMS system is a digital product that provides online management and analysis of operational modules such as progress, quality, and risk throughout the entire clinical trial process to control clinical research quality, improve efficiency, provide early risk warnings, and reduce costs.


01

Efficient project management to improve project visibility and control

With a visual interface, easy-to-use features, and an intelligent system, the project management team gains clear visibility at a glance and comprehensive control over project progress.


Article figure


Article figure


02

Comprehensive monitoring workflows to improve monitoring efficiency and satisfaction

Equipped with optimized monitoring visit workflows, built-in monitoring report templates, and system and email reminders, it also allows immediate retrieval of system data to support drafting monitoring reports and follow-up letters, with one-click letter dispatch to improve monitoring efficiency.


Article figure



03

Interconnected system design to maximize the value of platform data

It integrates seamlessly with other systems on the unified cloud platform, such as eTMF and EDC, and connects easily with other mainstream systems to effectively consolidate real-time data from multiple clinical systems.


Article figure



What are the functional features of EClinCloud CTMS?

Article figure



What services does EClinCloud CTMS provide?

1

Rapid deployment and go-live

Rapid deployment based on the sponsor's or CRO's SOPs, saving 30% of the time compared with the industry average.

2

Customized training

Multiple formats of user training tailored to the sponsor's or CRO's specific workflows.

3

Comprehensive after-sales service

Comprehensive after-sales support is provided after system go-live, including rapid response to requests and resolution of customer issues.

4

Multidisciplinary professional team support

Support from a multidisciplinary professional team across pre-sales, product, clinical, and R&D to continuously optimize the user experience.




Why choose EClinCloud CTMS?

Article figure



| About EClinCloud |

EClinCloud is a healthcare and life sciences technology company rooted in China and serving the world. Guided by the mission of "bringing effective treatments to patients through technological innovation" and driven by science and medicine, it combines digital technology with life data to build an end-to-end digital clinical trial cloud platform and provide technical solutions for clinical endpoint assessment, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the time to market for drugs and medical devices, and benefit countless patients.



Article figure

Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.